The goal should be balancing access with responsible spending.
But you should: What Happens Next
Table of Contents Introduction Expanded Indications for GLP-1 Receptor Agonists Emerging Therapies and Oral GLP-1 Options Cardiovascular and Renal Benefits Safety Considerations and Adverse Effects Conclusion FAQs Introduction Imagine a single class of medication that not only manages blood glucose but also offers cardiovascular and renal protection, aids in weight loss, and potentially reduces cancer risk
Guivarc P.-H
[DOI] [PMC free article] [PubMed] [Google Scholar] 292.Keenan S.J., Cooke M.B., Hassan E.B., Chen W.S., Sullivan J., Wu S.X., El-Ansary D., Imani M., Belski R
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine